The biotech giant says it’s costing more to collect the key ingredient for its medicines as it seeks to lure donors to its collection centres.
Business / Companies
Brisbane Times – Business
Business
More in:Business
Business
Westpac boss sees case for rate cuts after fall in inflation
The boss of Australia’s second-biggest retail bank says the number of people falling behind on ...
Business
ATO reviews decision to dump Keating tax bill
The tax office said it would review a decision to write off more than $950,000 ...
Business
Ozempic drugmaker just became a victim of its own success
For blame, look no further than pirates and the president (Trump, of course). Business / ...